Daniel Kientz - Concepedia

Author

Daniel Kientz

Cerus (United States)

Also Known As

D Kientz, D. Kientz, Daniel Geissert Kientz, Daniel Kientz, Kientz, D, Marie-Louise Wiesel

Publications

663

Citations

H-Index

Concepts

All Affiliations

Cerus (United States)Établissement Français du Sang Hôpitaux Universitaires de Strasbourg American Rock Mechanics Association Hôpital Civil, Strasbourg

About

Daniel Kientz is an author at Cerus (United States) specializing in medicine, patient safety, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	38
2	Business	1	1	12
3	Allergy	1	1	10
4	Health Informatics	1	1	12
5	Immunology	1	1	16

Daniel Kientz

Publications

538

Citations

H-Index

Page 1

	Year	Citations
Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set Karin Janetzko, Jean‐Pierre Cazenave, Harald Klüter, Transfusion	2005	118
Transfusion of platelet components prepared with photochemical pathogen inactivation treatment during a Chikungunya virus epidemic in Ile de La Réunion P. Rasonglès, Marie France Angelini‐Tibert, P L Simon, Transfusion	2009	112
Use of additive solutions and pathogen inactivation treatment of platelet components in a regional blood center: impact on patient outcomes and component utilization during a 3‐year period Jean‐Pierre Cazenave, Hervé Isola, C. Waller, Transfusion	2010	78
Photochemical treatment of plasma with amotosalen and UVA light: process validation in three European blood centers Peter Schlenke, Tor Hervig, Hervé Isola, Transfusion	2008	48
An active hemovigilance program characterizing the safety profile of 7483 transfusions with plasma components prepared with amotosalen and UVA photochemical treatment Jean‐Pierre Cazenave, C. Waller, Daniel Kientz, Transfusion	2010	47
Hypersensitivity transfusion reactions to platelet concentrate: a retrospective analysis of the French hemovigilance network Paul‐Michel Mertès, Charles Tacquard, Georges Andreu, Transfusion	2019	24
Impact of <scp>COVID</scp>‐19 and lockdown regarding blood transfusion Xavier Delabranche, Daniel Kientz, Charles Tacquard, Transfusion	2021	18
Assessment of complement activation during membrane‐based plasmapheresis procedures Thierry Burnouf, M. Eber, Daniel Kientz, Journal of Clinical Apheresis	2004	17
Prevention of transfusion‐transmitted cytomegalovirus (CMV) infection: Standards of care Lani Lieberman, Dana V. Devine, H. W. Reesink, Vox Sanguinis Transfusion MedicinePathogenesisPatient SafetyImmunologyPathogen-inactivated Product	2014	16
Comparative effectiveness of plasma prepared with amotosalen‐UVA pathogen inactivation and conventional plasma for support of liver transplantation J Cinqualbre, Daniel Kientz, Emilie Remy, Transfusion	2015	16

Page 1